Colgate-Palmolive vs. Kimberly-Clark: Which Household Name Deserves Your Investment Dollars?

Source The Motley Fool

Key Points

  • Colgate-Palmolive maintains a dominant global position in oral care while diversifying its growth through a specialized pet nutrition segment.

  • Kimberly-Clark provides essential personal and family care products with a focus on improving margins and optimizing its global supply chain.

  • Which consumer staple giant is the better fit for your portfolio?

  • 10 stocks we like better than Colgate-Palmolive ›

Investors often turn to reliable household brands when volatility hits the market. Choosing between Colgate-Palmolive (NYSE:CL) and Kimberly-Clark (NASDAQ:KMB) means deciding which defensive giant can absorb market shocks the best while still rewarding long-term shareholders.

Colgate-Palmolive focuses heavily on its market-leading oral care segment while expanding its reach in pet nutrition. Kimberly-Clark relies on its dominance in essential items like tissues and diapers. Both companies are staples in the retail landscape, but their differing balance sheet structures and growth strategies set them apart for investors.

The case for Colgate-Palmolive

Colgate-Palmolive operates as a global leader in oral care, personal care, and home care. It also owns Hill's Pet Nutrition, which serves the growing pet food market. The company sells its products through a vast network of retailers and distributors, with Walmart (NASDAQ:WMT) representing nearly 11% of its net sales. Customer concentration like this adds a layer of risk to the business.

In its latest annual report, filed for FY 2025, revenue reached nearly $20.4 billion. This represented growth of roughly 1.4% compared to the prior year. The company reported net income of approximately $2.1 billion during the same period. This sector remains popular among investors looking at consumer staples stocks.

The case for Kimberly-Clark

Kimberly-Clark produces essential products for personal and family care, including brands like Kleenex and Huggies. Its business is organized across major global markets and a dedicated professional segment. Walmart is its largest customer, accounting for approximately 16% of net sales in 2025. Customer concentration like this adds a layer of risk to the business.

In its latest annual report, filed for FY 2025, revenue reached nearly $16.4 billion. This reflected a decline of roughly 2.1% from the previous year. Despite the lower top line, the company generated net income of close to $2 billion. Its net margin for this period sat at approximately 12.3%, indicating the percentage of revenue that remains as profit after all expenses.

Risk profile comparison

Colgate-Palmolive faces intense global competition from other major brands and private-label products. International operations expose it to foreign currency fluctuations and geopolitical instability. The company is also subject to ongoing talc-related litigation and recently recognized an impairment charge related to its skin health business. Rivalry from Procter & Gamble (NYSE:PG) remains a constant factor in its core markets.

Kimberly-Clark faces risks from volatile raw material costs, particularly for pulp and petroleum-based materials. The company must also successfully navigate the integration of its Kenvue acquisition while fighting for market share against branded and private-label competitors. It is exposed to international market risks and potential supply chain disruptions.

Valuation comparison

Kimberly-Clark appears more attractively priced based on its lower forward price-to-earnings (P/E) ratio compared to the premium valuation given to Colgate-Palmolive.

MetricColgate-PalmoliveKimberly-Clark
Forward P/E24.3x14.7x
P/S ratio3.7x2.2

Which stock should you buy?

Stocks that have boosted their dividend payouts for 50 or more consecutive years are considered Dividend Kings, and both Colgate-Palmolive and Kimberly-Clark have earned that title. Colgate-Palmolive has increased its dividend payout for 64 consecutive years, while Kimberly-Clark has increased its dividend payout for 54 consecutive years. In that regard, both are reliable companies, and they've shown that their business models are strong, as the ability to keep boosting dividends that long is no small task.

Still, between the two, the difference boils down to whether an investor believes Colgate-Palmolive can be more successful with a growing portion of its revenue coming from pet food, or whether Kimberly-Clark can be more successful with an expanded portfolio of hygiene and health products, thanks to its recent acquisition of Kenvue. That acquisition now puts Tylenol, Band-Aid, and Neutrogena, just to name a few brands, under the Kimberly-Clark umbrella. The long-term risk, however, is that the Kenvue acquisition won't deliver the synergy Kimberly-Clark expected.

In comparison, Colgate-Palmolive's Hill's Pet Nutrition brand generated a whopping $1.2 billion in the third quarter of 2026, increasing 5.5% from the prior-year period. That accounted for 22% of the company's total sales. That pairs a potential revenue growth engine in pet food for the company with its steady oral, personal, and home care segment, which generated $4.1 billion in the third quarter.

Should you buy stock in Colgate-Palmolive right now?

Before you buy stock in Colgate-Palmolive, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Colgate-Palmolive wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $335,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,000,640!*

Now, it’s worth noting Stock Advisor’s total average return is 823% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of November 15, 2026.

Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Colgate-Palmolive and Walmart. The Motley Fool recommends Kimberly-Clark. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 3, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 3, 2026. Read on for the details.
Author  Mitrade
Nov 03, Tue
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 3, 2026. Read on for the details.
placeholder
Nvidia slid 7.7% after hours while AMD and Broadcom rose — the AI trade changed hands, it didn't breakNvidia closed Wednesday at 173.73, up 2.87%, then fell as much as 8.1% to 159.44 after reports that its board was preparing for a possible leadership change. The same session, the Philadelphia Semiconductor Index rose 5.7% with all 30 components higher, CoreWeave jumped 24.7% on 168% revenue growth, and Micron added 11.9%. If AI demand were being repriced, AMD and Broadcom would not be bid. This is a governance discount on one name, and 204.54 — the 200-day average — is the level that settles it.
Author  Irene Q.
Nov 12, Thu
Nvidia closed Wednesday at 173.73, up 2.87%, then fell as much as 8.1% to 159.44 after reports that its board was preparing for a possible leadership change. The same session, the Philadelphia Semiconductor Index rose 5.7% with all 30 components higher, CoreWeave jumped 24.7% on 168% revenue growth, and Micron added 11.9%. If AI demand were being repriced, AMD and Broadcom would not be bid. This is a governance discount on one name, and 204.54 — the 200-day average — is the level that settles it.
placeholder
Gold closed below $4,000 again — the ETF crowd and central banks stayed, the momentum money leftSpot gold is trading near $3,999, its third consecutive lower daily low, after a 5.00% 10-year yield and a 102.85 dollar index raised the odds of a December hike to 87%. But the selling is not coming from the strategic holders: managed-money net longs fell to 324 tonnes, a 21-week low, and Goldman Sachs attributes roughly 95% of five weeks of selling to non-reportable positions. ETFs still hold a record 4,256 tonnes and central banks bought 321 tonnes in Q3. The table below sets the triggers, directions and levels.
Author  Irene Q.
Nov 12, Thu
Spot gold is trading near $3,999, its third consecutive lower daily low, after a 5.00% 10-year yield and a 102.85 dollar index raised the odds of a December hike to 87%. But the selling is not coming from the strategic holders: managed-money net longs fell to 324 tonnes, a 21-week low, and Goldman Sachs attributes roughly 95% of five weeks of selling to non-reportable positions. ETFs still hold a record 4,256 tonnes and central banks bought 321 tonnes in Q3. The table below sets the triggers, directions and levels.
placeholder
Gold hit a one-year low while central banks bought 321 tonnes — the sellers were never the ones you thinkSpot gold closed at 3,876 on Thursday, down 2.8% and its lowest close in more than a year, with an intraday low near 3,852. The dollar is at a 19-month high of 103.21 and the 10-year yield is at 5.10%, so the price move is easy to explain. What is harder to explain is who sold: central banks bought 321 tonnes in Q3, the PBoC added for a 24th straight month, ETF holdings are near a record 4,256 tonnes, and roughly 95% of the futures selling came from non-reportable and sovereign-type accounts rather than hedge funds. This piece separates the two books that have to balance.
Author  Irene Q.
Nov 13, Fri
Spot gold closed at 3,876 on Thursday, down 2.8% and its lowest close in more than a year, with an intraday low near 3,852. The dollar is at a 19-month high of 103.21 and the 10-year yield is at 5.10%, so the price move is easy to explain. What is harder to explain is who sold: central banks bought 321 tonnes in Q3, the PBoC added for a 24th straight month, ETF holdings are near a record 4,256 tonnes, and roughly 95% of the futures selling came from non-reportable and sovereign-type accounts rather than hedge funds. This piece separates the two books that have to balance.
placeholder
Brent rose 3.3% and US crude stocks built 4.66 million barrels in the same weekBrent January settled at 95.82, up 3.3%, and WTI at 88.74, up 2.55%, after the US signalled it would not pursue a deal with Iran and attacks on Gulf shipping continued. In the same week, EIA data showed US crude inventories rising 4.657 million barrels against expectations of a 1.1 million draw, with gasoline up another 1.799 million. OPEC output also rebounded 1.96 million barrels a day to 27.16 million in October, led by Saudi Arabia at 10.56 million. This piece separates the geopolitical premium from the physical balance and lays out where each side of the trade is anchored.
Author  Irene Q.
Nov 13, Fri
Brent January settled at 95.82, up 3.3%, and WTI at 88.74, up 2.55%, after the US signalled it would not pursue a deal with Iran and attacks on Gulf shipping continued. In the same week, EIA data showed US crude inventories rising 4.657 million barrels against expectations of a 1.1 million draw, with gasoline up another 1.799 million. OPEC output also rebounded 1.96 million barrels a day to 27.16 million in October, led by Saudi Arabia at 10.56 million. This piece separates the geopolitical premium from the physical balance and lays out where each side of the trade is anchored.
goTop
quote